selegiline has been researched along with Bradykinesia in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belvisi, D; Berardelli, A; Bologna, M; Colella, D; Fabbrini, G; Fasano, A; Leodori, G; Paparella, G; Stirpe, P | 1 |
| Holford, NH; Nutt, JG; Vu, TC | 1 |
| Endo, T; Hamaue, N; Hirafuji, M; Hiroshige, T; Machida, M; Minami, M; Ogata, A; Parvez, SH; Saito, H; Tashiro, K; Terado, M | 1 |
| Bhat, V; Weiner, WJ | 1 |
| Bertoni, J; Kricorian, G; Leehey, M; Lew, MF; Pahwa, R | 1 |
| Bowes, SG; Charlett, A; Dickins, J; Dobbs, RJ; Dobbs, SM; Faulkner, G; Hunt, WB; Kirollos, C; Nicholson, PW; O'Neill, CJ; Purkiss, AG; Weller, C | 1 |
| Archer, T; Eriksson, P; Fredriksson, A | 1 |
1 review(s) available for selegiline and Bradykinesia
| Article | Year |
|---|---|
Parkinson's disease. Diagnosis and the initiation of therapy.
Topics: Antioxidants; Diagnosis, Differential; Dopamine Agonists; Humans; Hypokinesia; Indans; Levodopa; Muscle Rigidity; Nerve Degeneration; Neuroprotective Agents; Parkinson Disease; Parkinsonian Disorders; Selegiline; Tremor | 2005 |
2 trial(s) available for selegiline and Bradykinesia
| Article | Year |
|---|---|
Safety and efficacy of newly formulated selegiline orally disintegrating tablets as an adjunct to levodopa in the management of 'off' episodes in patients with Parkinson's disease.
Topics: Administration, Oral; Aged; Antiparkinson Agents; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Drug Therapy, Combination; Female; Humans; Hypokinesia; Levodopa; Male; Middle Aged; Parkinson Disease; Placebos; Polypharmacy; Selegiline; Tablets; Time Factors; Treatment Outcome | 2007 |
Time course of physical and psychological responses to selegiline monotherapy in newly diagnosed, idiopathic parkinsonism.
Topics: Aged; Antiparkinson Agents; Arousal; Double-Blind Method; Female; Gait; Humans; Hypokinesia; Male; Muscle Rigidity; Parkinson Disease; Posture; Psychomotor Performance; Research Design; Selegiline; Treatment Outcome; Tremor | 1996 |
4 other study(ies) available for selegiline and Bradykinesia
| Article | Year |
|---|---|
Bradykinesia in early and advanced Parkinson's disease.
Topics: Aged; Biomechanical Phenomena; Case-Control Studies; Female; Humans; Hypokinesia; Male; Middle Aged; Neuroprotective Agents; Parkinson Disease; Selegiline; Severity of Illness Index | 2016 |
Progression of motor and nonmotor features of Parkinson's disease and their response to treatment.
Topics: Antiparkinson Agents; Cognition Disorders; Depression; Disability Evaluation; Disease Progression; Drug Substitution; Drug Therapy, Combination; Gait Disorders, Neurologic; Humans; Hypokinesia; Linear Models; Motor Activity; Nonlinear Dynamics; Parkinson Disease; Patient Dropouts; Postural Balance; Predictive Value of Tests; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Retrospective Studies; Selegiline; Sensation Disorders; Severity of Illness Index; Surveys and Questionnaires; Time Factors; Tocopherols; Treatment Outcome; Tremor | 2012 |
Comparative study of the effects of isatin, an endogenous MAO-inhibitor, and selegiline on bradykinesia and dopamine levels in a rat model of Parkinson's disease induced by the Japanese encephalitis virus.
Topics: Animals; Disease Models, Animal; Dopamine; Encephalitis Virus, Japanese; Hypokinesia; Isatin; Mice; Monoamine Oxidase Inhibitors; Parkinson Disease; Rats; Selegiline | 2004 |
MPTP-induced deficits in motor activity: neuroprotective effects of the spintrapping agent, alpha-phenyl-tert-butyl-nitrone (PBN).
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Analysis of Variance; Animals; Cyclic N-Oxides; Dopamine; Free Radical Scavengers; Hypokinesia; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Nitrogen Oxides; Selegiline; Spin Trapping | 1997 |